AT333953B - Verfahren zur herstellung von neuen 7-alpha-aminoacyl-3-halogencephalosporinen - Google Patents

Verfahren zur herstellung von neuen 7-alpha-aminoacyl-3-halogencephalosporinen

Info

Publication number
AT333953B
AT333953B AT142574A AT142574A AT333953B AT 333953 B AT333953 B AT 333953B AT 142574 A AT142574 A AT 142574A AT 142574 A AT142574 A AT 142574A AT 333953 B AT333953 B AT 333953B
Authority
AT
Austria
Prior art keywords
halogencephalosporines
aminoacyl
alpha
preparation
new
Prior art date
Application number
AT142574A
Other languages
German (de)
English (en)
Other versions
ATA142574A (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA142574A publication Critical patent/ATA142574A/de
Application granted granted Critical
Publication of AT333953B publication Critical patent/AT333953B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT142574A 1973-02-23 1974-02-21 Verfahren zur herstellung von neuen 7-alpha-aminoacyl-3-halogencephalosporinen AT333953B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33538173A 1973-02-23 1973-02-23

Publications (2)

Publication Number Publication Date
ATA142574A ATA142574A (de) 1976-04-15
AT333953B true AT333953B (de) 1976-12-27

Family

ID=23311540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT142574A AT333953B (de) 1973-02-23 1974-02-21 Verfahren zur herstellung von neuen 7-alpha-aminoacyl-3-halogencephalosporinen

Country Status (37)

Country Link
JP (4) JPS6139313B2 (ja)
AR (1) AR199510A1 (ja)
AT (1) AT333953B (ja)
BE (1) BE811495A (ja)
BR (1) BR7401384D0 (ja)
CA (1) CA1016537A (ja)
CH (1) CH593988A5 (ja)
CS (1) CS187409B2 (ja)
CY (1) CY1043A (ja)
DD (1) DD110278A5 (ja)
DE (1) DE2408698C2 (ja)
DK (1) DK153157C (ja)
EG (1) EG11104A (ja)
ES (1) ES423531A1 (ja)
FI (1) FI63035C (ja)
FR (1) FR2218877B1 (ja)
GB (1) GB1461323A (ja)
GT (1) GT197432133A (ja)
HK (1) HK20080A (ja)
HU (1) HU166849B (ja)
IE (1) IE39046B1 (ja)
IL (1) IL44262A (ja)
IN (1) IN139620B (ja)
KE (1) KE3027A (ja)
MW (1) MW674A1 (ja)
MY (1) MY8100024A (ja)
NL (1) NL179057C (ja)
NO (2) NO148375C (ja)
OA (1) OA04809A (ja)
PH (1) PH9616A (ja)
PL (1) PL88702B1 (ja)
RO (1) RO64663A (ja)
SE (1) SE411212B (ja)
SU (1) SU676166A3 (ja)
YU (1) YU36970B (ja)
ZA (1) ZA741191B (ja)
ZM (1) ZM3574A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342197B (de) * 1975-02-20 1978-03-28 Ciba Geigy Ag Neues verfahren zur herstellung von 3-cephemverbindungen
CH619233A5 (ja) * 1975-07-31 1980-09-15 Ciba Geigy Ag
CH622802A5 (ja) * 1975-08-20 1981-04-30 Ciba Geigy Ag
IE45158B1 (en) * 1976-08-16 1982-06-30 Lilly Co Eli 3-chloro-cephem synthesis
DE3508258A1 (de) * 1985-03-08 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
DE3509618A1 (de) 1985-03-16 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactam-antibiotika, verfahren zur herstellung und ihre verwendung als arzneimittel
JPS6436445U (ja) * 1987-08-28 1989-03-06
DE3803169A1 (de) 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln
ES2010075A6 (es) * 1989-01-10 1989-10-16 Antibioticos Sa Un procedimiento para la preparacion de compuestos de 3-cloro-cefem.
JP2539459Y2 (ja) * 1991-12-18 1997-06-25 三重ホーロー株式会社 組立式塵芥焼却器
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati
ES2079327B1 (es) 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
CN101805357B (zh) * 2010-04-28 2012-01-11 陶灵刚 一种头孢克洛化合物及其制法
CN103588790A (zh) * 2013-11-29 2014-02-19 中国科学院长春应用化学研究所 7-氨基-3-氯-3-头孢-4-羧酸-对硝基苄基酯的制备方法
CN106632400A (zh) * 2016-12-16 2017-05-10 石家庄柏奇化工有限公司 Pd‑C催化氢化脱除4‑硝基苄基制备7‑ACCA的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
DE2265798C2 (de) * 1971-06-24 1985-09-26 Fujisawa Pharmaceutical Co., Ltd., Osaka Verfahren zur Herstellung von Oxoazetidin-Derivaten
AR206201A1 (es) * 1972-06-29 1976-07-07 Ciba Geigy Ag Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos

Also Published As

Publication number Publication date
NO148377B (no) 1983-06-20
JPS6140237B2 (ja) 1986-09-08
CA1016537A (en) 1977-08-30
PH9616A (en) 1976-01-20
FI63035B (fi) 1982-12-31
CS187409B2 (en) 1979-01-31
NO148377C (no) 1983-09-28
JPS6140235B2 (ja) 1986-09-08
YU36970B (en) 1984-08-31
IN139620B (ja) 1976-07-10
EG11104A (en) 1976-12-31
PL88702B1 (ja) 1976-09-30
SU676166A3 (ru) 1979-07-25
DE2408698A1 (de) 1974-09-05
IL44262A0 (en) 1974-05-16
JPS56138190A (en) 1981-10-28
CY1043A (en) 1980-08-01
CH593988A5 (ja) 1977-12-30
IE39046B1 (en) 1978-07-19
FR2218877B1 (ja) 1977-03-11
JPS56138192A (en) 1981-10-28
ATA142574A (de) 1976-04-15
JPS56138191A (en) 1981-10-28
JPS6139313B2 (ja) 1986-09-03
OA04809A (fr) 1980-08-31
IE39046L (en) 1974-08-23
JPS49110689A (ja) 1974-10-22
AU6591674A (en) 1975-08-28
NO148375C (no) 1983-09-28
AR199510A1 (es) 1974-09-09
MY8100024A (en) 1981-12-31
NL179057B (nl) 1986-02-03
NO740606L (no) 1974-08-26
RO64663A (fr) 1979-02-15
HU166849B (ja) 1975-06-28
DK153157C (da) 1988-10-31
FR2218877A1 (ja) 1974-09-20
ZA741191B (en) 1975-10-29
KE3027A (en) 1980-03-14
MW674A1 (en) 1975-04-09
DK153157B (da) 1988-06-20
ZM3574A1 (en) 1975-11-21
FI63035C (fi) 1983-04-11
DE2408698C2 (de) 1983-11-10
NO792681L (no) 1974-08-26
ES423531A1 (es) 1976-05-16
HK20080A (en) 1980-04-25
JPS6140236B2 (ja) 1986-09-08
GT197432133A (es) 1975-08-16
GB1461323A (en) 1977-01-13
NL179057C (nl) 1986-07-01
NO148375B (no) 1983-06-20
SE411212B (sv) 1979-12-10
IL44262A (en) 1977-08-31
YU39974A (en) 1982-06-18
BE811495A (fr) 1974-08-22
NL7402489A (ja) 1974-08-27
BR7401384D0 (pt) 1974-11-05
DD110278A5 (ja) 1974-12-12

Similar Documents

Publication Publication Date Title
AT333726B (de) Verfahren zur herstellung von neuen n-cinnamoyl- oder hydrocinnamoylaminobenzoesauren
AT342793B (de) Verfahren zur herstellung von neuen cholesteranen
AT330761B (de) Verfahren zur herstellung von neuen acylaminosaureamiden
AT333953B (de) Verfahren zur herstellung von neuen 7-alpha-aminoacyl-3-halogencephalosporinen
AT337698B (de) Verfahren zur herstellung von neuen 2-hydroxyphenyl -1-oxa-4- azaspiro-alkan- derivaten
AT338248B (de) Verfahren zur herstellung von neuen 2-aminoalkanoylamidobenzophenonen
AT343292B (de) Verfahren zur herstellung von neuen steroid-3-oxim-derivaten
AT330161B (de) Verfahren zur herstellung von neuen biphenylbutanolen
AT348536B (de) Verfahren zur herstellung von neuen 4-oxo-2- imidazolidinylidenharnstoffen
AT337201B (de) Verfahren zur herstellung von neuen 5-phenylsulfinylbenzimidazolyl-2-carbaminsaurealkylestern
AT339283B (de) Verfahren zur herstellung von neuen 3,4-diamino-benzophenonen
AT335449B (de) Verfahren zur herstellung von neuen thiadiazolylimidazolidinonen
AT341509B (de) Verfahren zur herstellung von neuen chloracetaniliden
AT331780B (de) Verfahren zur herstellung von neuen 3-n-butylamino-4-phenoxy-5-alkoxymethyl-sulfamoylbenzoesauren
AT327950B (de) Verfahren zur herstellung von neuen 1,2-oxaphospholanen
AT325059B (de) Verfahren zur herstellung von neuen thiazolotriazolylphosphonothioaten
AT343685B (de) Verfahren zur herstellung von neuen d-xylofuranose-derivaten
ATA695076A (de) Verfahren zur herstellung von neuen 5-methyl-7-hydroxy-isoflavon-derivaten
ATA722475A (de) Verfahren zur herstellung von neuen 3-n-butylamino- 4-phenoxy-5 -alkoxymethyl-sulfamoylbenzoesauren
ATA722375A (de) Verfahren zur herstellung von neuen 3-n-butylamino-4-phenoxy-5-alkoxymethyl-sulfamoylbenzoesauren
ATA895275A (de) Verfahren zur herstellung von neuen derivaten des digitoxigenin-alfa-l-arabinosids
ATA895175A (de) Verfahren zur herstellung von neuen derivaten des digitoxigenin-alfa-l-arabinosids
AT341502B (de) Verfahren zur herstellung von neuen 3,4-diamino-benzophenonen
ATA746976A (de) Verfahren zur herstellung von neuen 3,4-diamino-benzophenonen
ATA691775A (de) Verfahren zur herstellung von neuen 1,1-diphenyl -2-hydroxy-3- aminopropanderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
EWE Authorization for restitution
ELA Expired due to lapse of time
REN Ceased due to non-payment of the annual fee